Navigation Links
Roche Acquires Verum Diagnostica GmbH as Part of Plan to Develop Comprehensive Coagulation Testing Portfolio for Diagnostic Laboratories
Date:12/5/2011

INDIANAPOLIS, Dec. 5, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany. Verum Diagnostica is a leading company in platelet function testing, the fastest-growing field in the coagulation diagnostics market.

The acquisition supports plans Roche announced in October to expand its coagulation testing product line in North America beyond physician offices and outpatient clinics with the development of a full line of coagulation analyzers for hospital and reference laboratories. The new line is expected to be introduced in the U.S. and Canada in 2014, subject to regulatory approval and other requirements.

"Improving the assessment of a patient's platelet function status is currently a significant unmet need for hematologists, cardiologists and anesthetists in order to support clinical decisions in cardiology, surgery and intensive care," said Colin Brown, Head of Roche Professional Diagnostics. "With this acquisition we gain an innovative and unique platelet function testing solution which has the potential to set new standards of patient care in this area and perfectly complements our new coagulation portfolio." Coagulation diagnostics has become an important area in clinical diagnostics and Roche has already begun to make significant investments in this field.

Under the terms of the acquisition agreement, Roche will pay Verum Diagnostica shareholders a total cash consideration of eleven million euros, and potentially a further two million euros contingent upon reaching certain performance-related milestones. The transaction is subject to customary closing conditions and is expected to close in January 2012.

Laboratory coagulation is estimated to be the fifth-largest market in professional diagnostics worldwide, representing approximately 1.3 billion USD in sales in 2010 and having a projected
'/>"/>

SOURCE Roche Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Roche, ChanTest Collaborate for Preclinical Cardiac Safety Testing of Drug Compounds Using iCell Cardiomyocytes and xCELLigence RTCA Cardio Instrument
2. Roche Diagnostics, Cedars-Sinai Medical Center Enter Strategic Alliance for Center to Operate as a Roche Molecular Center of Excellence
3. Rochester Medical Reports Fourth Quarter and Fiscal Year End Results
4. Roche Receives FDA Approval for Acute Hepatitis B Test
5. Rochester Medical Announces Fourth Quarter 2011 Earnings Conference Call Thursday, November 3, 2011
6. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
7. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys Pharmaceuticals Inc. in Connection with the Sale of the Company to Roche Holding AG
8. Hyam Levitsky Joins Roche as Head of Cancer Immunology Experimental Medicine
9. Rochester Medical Implants Relocates to New Facility in Noblesville, IN
10. Anadys Announces Agreement To Be Acquired By Roche
11. Study Shows That Roches Investigational Drug for Alzheimers Disease Removes Amyloid Plaques From the Brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Novation, the leading health care supply chain expertise, analytics ... (VAR) national contracts that expand its portfolio to provide ... costs. These include manufacturer product and service agreements, as ... ongoing IT consulting support. New Novation ...
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... , June 2 Today, the U.S. Food and Drug ... active ingredient known as a long-acting beta-agonist (LABA).  This follows the FDA ... medications to undertake class-labeling changes. , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) , ...
... , June 2 GlaxoSmithKline (NYSE: ... a letter from the U.S. Food and Drug Administration ... Serevent® and Advair®.  The letter concludes discussions between GSK ... the safety profile of long-acting beta2-agonists in the treatment ...
Cached Medicine Technology:FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 2FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 3FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 4FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 5FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 6GSK Announces Revised Product Labels for Serevent® and Advair® 2
(Date:4/23/2014)... Moffitt Cancer Center researchers say clinical trials for ... leukemia (AML) are very promising. Patients treated with ... and daunorubicin, are showing better responses than patients ... , "Acute myeloid leukemia is an aggressive ... success, especially in older patients," explained Jeffrey Lancet, ...
(Date:4/23/2014)... O,Shea, M.D., scientific director at the National Institute of ... named the 2014 recipient of the Ross Prize in ... journal Molecular Medicine . The award will be ... of Sciences in Manhattan, followed by scientific presentations by ... of the National Institutes of Health. , The award, ...
(Date:4/23/2014)... Society for Radiation Oncology (ASTRO) has issued a ... for Endometrial Cancer: An ASTRO Evidence-Based Guideline," that ... the treatment of endometrial cancer. The guideline,s executive ... of Practical Radiation Oncology (PRO), the ... guideline is available as an open-access article online ...
(Date:4/23/2014)... - Purdue University researchers have developed a way to ... by using tiny gold particles with tails of synthetic ... agricultural and biological engineering, used gold nanoparticles to target ... BRCA1 messenger RNA splice variants, which can indicate the ... these mRNA splice variants in a cell can be ...
(Date:4/23/2014)... targets an important brain receptor has a dramatic effect ... behavior, a University at Buffalo animal study has found. ... be a novel lead compound for treating cocaine addiction, ... was published as an online preview article in ... compound, RO5263397, severely blunted a broad range of cocaine ...
Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Gold nanoparticles help target, quantify breast cancer segments in a living cell 2Health News:Novel compound halts cocaine addiction and relapse behaviors 2
... ... Flying Marijuana Bud Banner On Labor Day Weekend , ... Seattle, WA (PRWEB) September 4, 2009 -- When Labor Day crowds ... a flying marijuana bud on a massive banner along with the words "Want Big, Sugary ...
... ... Channel on the Fast Growth 100 list. The Fast Growth 100 recognizes the fastest growing ... , ... 4, 2009 -- Netelligent today announced that it has been recognized by Everything Channel on ...
... ... its short term medical insurance product to HCC Life Short Term Medical (STM). , ... Indianapolis, IN (PRWEB) September 3, 2009 ... term medical insurance product to HCC Life Short Term Medical (STM). Formerly known ...
... , , PALO ALTO, Calif., ... announced today that company management will present a corporate overview at ... Myers, President of Jazz Pharmaceuticals, will speak at the Rodman & ... 3:15 p.m. EDT at the Palace Hotel in New York City. ...
... say more research is needed , THURSDAY, Sept. 3 (HealthDay ... a new Danish study indicates they might also raise the ... and women. , That,s not to say fat thighs confer ... nearly 3,000 men and women who were followed for more ...
... , , , SAN FRANCISCO, ... will be ensuring expedited access to needed prescriptions and mental health ... California. , , "During this taxing and difficult ... people impacted by the wildfires to continue to have uninterrupted access ...
Cached Medicine News:Health News:Labor Day Beach Visitors Will See Giant Hydroponics Marijuana Bud Banner Flying Over Los Angeles & San Diego 2Health News:Labor Day Beach Visitors Will See Giant Hydroponics Marijuana Bud Banner Flying Over Los Angeles & San Diego 3Health News:Netelligent Recognized on the Everything Channel Fast Growth 100 List at #13 2Health News:Netelligent Recognized on the Everything Channel Fast Growth 100 List at #13 3Health News:HCC Life Insurance Company Renames Short Term Medical Insurance 2Health News:Thin Thighs Might Be Harbinger of Heart Disease 2Health News:Blue Shield of California Streamlines Access to Benefits and Prescriptions for Wildfire Victims 2
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... Model C-18 is made of ... padding. Front and back sections ... larger openings to facilitate air ... is lightweight and washable. Model ...
Ezy Wrap® Economy Contour Cervical Collar Medium-density urethane foam. Synthetic white stockinette cover. Reverses for flexion or extension. (Contact closure. Hand wash. Air dry. 10/pack.)...
... improves patient compliance, prevent skin breakdown ... user's anatomy, wicks moisture, and evenly ... shoulders and upper throacic. Fits upright ... airflow openings. Adjustable Occipital Support Strap™ ...
Medicine Products: